StockWatch
·

Vintage Coffee And Beverages Ltd Q2 FY27 Results

VINCOFEQ2 FY27 Results
Filing
Result:Steady· Market: Surged#Margin squeeze#Record quarter#Base effect

Outlook: Optimistic · Guidance: Cut

MetricValue (₹ Cr)vs Q1 FY27
Revenue222.9738.5%
Total Income224.6638.2%
Expenditure186.7038.6%
PBT37.9736.2%
Net Profit28.0635.0%
OPM—
NPM12.49%0.30pp
EPS1.9234.3%
View full financials

FMCG core metric (revenue/adjusted PAT growth) is genuinely strong on a like-for-like QoQ basis (+38.5%/+35%, a 6-quarter high) but OPM/NPM compressed sequentially and the flashy YoY headline is inflated by a merger-driven consolidation-scope change rather than pure organic growth, so it's healthy but not margin-supportive enough for very_good.

VINCOFE · Q2 FY27 · THE VERDICT

Strong Organic Delivery, But the Catalyst Is Delayed

Vintage delivered 64% YoY revenue growth on 100% capacity utilization — real numbers, no one-time gains. But the marquee catalyst (freeze-dried coffee plant) is pushed back 6 months, and the market has marked the stock down 18% from its all-time high on execution concerns.

11 Nov 2026 · 6 min read
Reported PAT

₹28.1 Cr

+57.3% YoY

EBITDA margin

18.9%

+244 bps YoY

Capacity utilization

100%

11,000 MTPA spray-dried

Vintage Coffee delivered a genuinely strong organic quarter — 64% revenue growth on 100% utilization of the 11,000 MTPA spray-dried plant, with EBITDA margin expanding 244 basis points to 18.9%. No MTM gains, no tax anomalies, no inventory revaluations. The delivered profit is the organic one. And yet the stock has fallen 18% from its all-time high of ₹191.22. The gap between the operational story and the market's reaction is the tension of the quarter.

Where the growth came from

Revenue ₹223 Cr is volume-driven, not realization uplift. Q2 production came in at 2,737 MTPA, annualizing to ~10,950 MTPA — roughly 95% of the installed 11,000 MTPA capacity for spray-dried. The company has shifted product mix toward agglomerated coffee (55% of sales vs. 45% spray), which carries 2% higher margins, and this mix benefit is real and sustainable, not a one-time from chicory pricing or commodity tailwinds. Chicory production is capped — capacity is fully utilized — so volume growth there is limited to ~5% by crop constraints, not market demand. In short, the 64% top-line growth is the result of running a maxed-out plant and upgrading the product into higher-margin formats.

Management's claims vs. what holds up

Revenue up 64.4% YoY with strong volume growth

Supported

Q2 production 2,737 MTPA annualizes to ~10,950 MTPA (95% of 11k capacity). Sales ₹223 Cr. Growth is volume, not pricing.

Achieved 100% utilization of 11,000 MTPA spray-dried capacity

Supported

Production 2,737 MTPA Q2 annualizes to ~10,950 MTPA, confirming ~95% sustained utilization. Plant is maxed.

16,500 MTPA by end of FY27; freeze-dried on track

Contradicted

FDC Phase 1 (5,500 MTPA) now coming Sept 2027 onwards (originally June-July), pushed 6 months. Phase 2 Sept 2029. Full 16,500 MTPA is now FY28–FY29, not FY27.

100% of freeze-dried capacity pre-booked by customers

Supported

Received letters of intent covering 100% of Phase 1 from buyers in Europe, US, Russia, SE Asia. Commitments are in writing.

What changed on this call

  • FDC timeline: June-July 2027 → Aug-Sept 2027 (6-month delay due to ESG compliance from European bank lender)

  • Full capacity target: 16,500 MTPA 'by end of FY27' → now FY28–FY29 with phased ramp

  • Funding strategy: Initially no equity planned → now exploring 'small equity dilution' for ₹550 Cr FDC capex due to negative pledge clause on foreign loans

  • B2C entry: Previously vague timing → now clarity: FY30 onwards (after FDC stabilizes and cash flows improve)

None of these are dealbreakers individually. The FDC timeline slip is a communications miss — management should have flagged 'the project was always designed to come online in H2 FY28, not FY27' more explicitly upfront. The funding being finalized (equity dilution being explored) suggests some tightness but the board approved ₹325 Cr fundraising and OCF is positive (₹51.16 Cr in H1), so there are multiple funding knobs to pull. What they do signal collectively is that the long-term thesis — 80-85% growth in FY28–FY29 when FDC ramps — is credible but now hinges on execution on a compressed, revised timeline.

Earnings quality: What normalizes next

Tax rate came in at 26.1% vs. the 25% expected full rate from Q4 FY26 onwards. This is normalizing but not there yet; expect a ₹0.3–0.4 Cr tailwind when it hits 25%. Gross margin of 27.6% (+293 bps YoY) is strong but moderated 133 bps QoQ — the chicory price uplift (4-5% due to crop scarcity) is a one-off benefit that will reverse if the crop recovers, and coffee input costs remain stable. The product mix shift to agglomerated is the real, repeatable driver of margin expansion. So adjusted PAT is approximately ₹28.1 Cr as reported (no one-time items to strip out), and the margin track record (244 bps EBITDA expansion YoY) is operational leverage, not a mirage.

Risks, ranked by how much they should concern a holder

FDC execution delay and capex overrun

High

Phase 1 already pushed 6 months (June-July to Aug-Sept 2027). ₹550 Cr capex is at risk from equipment sourcing, ESG compliance, installation delays. Any further slip would push off the 80-85% FY28–FY29 growth guidance. This is the marquee catalyst.

Geopolitical logistics and export margins

Medium

15% of revenue from exports (Europe, US, Russia, SE Asia). Container availability and shipping costs are headwinds. If demand softens, export margins could compress faster than domestic. Passed on to customers but margin risk if pricing power erodes.

Funding structure and equity dilution

Medium

Board approved ₹325 Cr fundraise for FDC capex; structure TBD. Foreign bank loans have negative pledge clause, limiting leverage options. If dilution is >5-10%, near-term EPS accretion muted. Execution risk on finalizing funding by the time FDC construction ramps.

Customer concentration on FDC pre-books

Low

100% of Phase 1 (5,500 MTPA) pre-booked to existing customers. Limits upside optionality if a new, higher-price market opens. But commitments are in writing; customer risk is lower. Phase 2 has more flexibility.

How the street is positioned

The stock is trading at ₹156.28, down 18% from its all-time high of ₹191.22. It's below the 20-day average (₹160.73) and the 50-day average (₹171.05) but above the 200-day average (₹151.91), signaling a downtrend with emerging support. Over the past 52 weeks, the stock has ranged from ₹120.24 to ₹191.22; today's price sits 30% above the low and 18% below the high. RSI is 44.6, neutral, leaving room for movement in either direction.

Institutional flows are net long: FII holding increased 55 basis points to 5.38% QoQ, while DII increased 196 basis points to 9.59%. Both are nibbling higher despite the 18% drawdown — a signal that big money sees value at current levels. Volume trend is increasing, which could indicate accumulation. Bulk deals in the past six months show no promoter selling near the highs; the only meaningful activity was HRTI buying 9.2 lakh shares at ₹184.97 and selling 6.6 lakh the same day in Aug (a short-term trade, not strategic positioning).

The market's own verdict: The 18% drawdown from ATH despite 64% organic revenue growth and 244 bps margin expansion reflects skepticism about the FDC catalyst and execution risk. The increases in FII and DII, combined with rising volume, suggest some institutions are buying the dip — interpreting the drawdown as an overreaction to the timeline slip, not a fundamental break. The honest reading: the market has priced in the FDC delay and some execution risk, and is now hunting for entry points on the conviction that the long-term thesis (80-85% growth in FY28–FY29) remains intact if management stays on the new schedule.

The debate

Bulls say: Vintage has proven operational chops (11k MTPA on time, now 100% utilized). 64% organic growth with margin expansion is real. The 5,500 MTPA FDC is a concrete cash driver with 100% customer pre-commitments locked in. 80-85% guidance for FY28–FY29 is achievable if FDC starts on the new Sept 2027 timeline. The 18% drawdown is a gift for long-term holders.

Bears counter: FDC is delayed 6 months and hasn't started yet. Freeze-dried is new for Vintage; execution risk is real. Funding is still being finalized (equity dilution possible). Geopolitical logistics (container scarcity, shipping costs) are headwinds on the 15% export revenue. If FDC delays push past Sept 2027, or if any of these execution risks bite, the 80-85% guidance is toast.

The honest read: Vintage delivered exactly what was promised on the spray-dried story — 100% utilization at 11k MTPA, margin expansion from mix shift, 64% organic growth. Management is credible on delivering, as evidenced by hitting the 11k capacity milestone by March 2026 as guided. The FDC delay is a 6-month push, not a year, and it's blamed on ESG compliance from a European bank, not operational chaos. The long-term thesis (80-85% growth in FY28–FY29, 2-3% margin uplift) is still on the table if management holds the Sept 2027 timeline and executes the funding raise without massive dilution. The 18% drawdown has likely priced in the delay and some execution risk; the real test is whether FDC starts on schedule in H2 FY28 and whether customer demand materializes as the 100% pre-bookings suggest. If both hold, the stock has room to run. If either slips, bears have a point.

What to watch next — the 2–3 things that resolve the debate
  • 1 · Q1 Q2 FY28: Spray-dried ramp endgame

    Management guided 5-10% QoQ growth in Q3–Q4 FY27 (seasonal slower quarters), with continued 100% utilization of 11k MTPA expected. Watch for delivery on this and any margin expansion updates. This is the 'show me' quarter on whether management can sustain near-term delivery while FDC is being built.

  • 2 · H2 FY28: FDC Phase 1 trial production and commercial ramp

    The Aug-Sept 2027 trial production timeline is the linchpin. Any delay here would push back the commercial ramp and the 80-85% FY28–FY29 growth thesis. Watch for management commentary on trial production progress, equipment delivery, customer takeoff, and any further timeline adjustments.

  • 3 · FY29: FDC utilization ramp and margin uplift realization

    Management guided for ~70% utilization of the 5,500 MTPA FDC in its first year (FY28) and a 2-3% margin uplift from the higher-margin freeze-dried product when it ramps. FY29 is when the margin story materializes. Watch for utilization, customer delivery, and margin realization against the 2-3% target.

Vintage delivered a strong organic quarter — 64% revenue growth on 100% utilization, 244 bps EBITDA margin expansion, and real volume-driven topline growth. No one-time items, no quality concerns. The operational story is solid and proven.

The market has marked the stock down 18% from its all-time high on concerns about FDC execution delays (6 months already pushed, still not started) and funding uncertainty (equity dilution being explored). These are real risks, not noise.

The long-term thesis — 80-85% growth in FY28–FY29 when the 5,500 MTPA freeze-dried plant ramps with 100% customer pre-commitments — remains credible if management holds the new Sept 2027 timeline and executes the funding raise without massive dilution. Management's track record (11k MTPA on time) suggests it can deliver.

Vintage is a steady-state compounder today (100% capacity utilization, mix shift to higher-margin products). The FDC ramp is a step-change catalyst that's been delayed 6 months but not derailed. The 18% drawdown has priced in the delay and execution risk. If FDC starts on schedule and customer demand holds, the stock has room to run. If delays extend or execution stumbles, the 80-85% guidance is at risk.

The number to track from here: FDC Phase 1 trial production timeline. If it stays on track for Aug-Sept 2027 with commercial ramp from Sept onwards, the 18% markdown is an opportunity. If it slips further, the bears have a point.

Informational and educational content only. Not investment advice.